Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-021617
Filing Date
2024-05-28
Accepted
2024-05-28 16:23:06
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 917570
2 ex31-1.htm EX-31.1 19301
3 ex31-2.htm EX-31.2 19149
4 ex32-1.htm EX-32.1 6783
5 ex32-2.htm EX-32.2 6439
6 image_001.jpg GRAPHIC 7881
  Complete submission text file 0001493152-24-021617.txt   5593219

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mrzm-20240331.xsd EX-101.SCH 41838
8 XBRL CALCULATION FILE mrzm-20240331_cal.xml EX-101.CAL 48800
9 XBRL DEFINITION FILE mrzm-20240331_def.xml EX-101.DEF 209530
10 XBRL LABEL FILE mrzm-20240331_lab.xml EX-101.LAB 355172
11 XBRL PRESENTATION FILE mrzm-20240331_pre.xml EX-101.PRE 285638
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 919664
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Filer) CIK: 0001413754 (see all company filings)

EIN.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53223 | Film No.: 24992189
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)